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Bovine rotavirus (BRV) V1005 is serologically distinct 
from rotavirus erotypes 1, 2, 3, 4, 5, 6, 8 and 9. BRV 
V1005 showed cross-reactions with BRV B223, the 
American prototype of serotype 10 rotavirus, and with 
BRV E4049, a British serotype 10 isolate. BRV V1005 
was, however, not neutralized by four monoclonal 
antibodies directed against VP7 of BRV B223. Two- 
way cross-reactions were observed between BRV 
V1005 and a reassortant rotavirus containing the 
VP4 from BRV UK. In addition the major tryptic 
cleavage product of VP4, VP5*, from BRV V1005 is 
indistinguishable bypeptide mapping and its isoelectric 
point from the homologous protein of BRV UK, hut is 
clearly different from VP5* of BRV NCDV. The 
peptide map of VP7 from BRV V1005 differed from 
that obtained for VP7 of BRV UK. 
Introduction 
Rotaviruses are now recognized as the most important 
cause of severe viral gastroenteritis in humans and young 
animals. Currently, 11 serotypes of rotavirus have been 
defined (Estes & Cohen, 1989). Six serotypes ( erotypes 
1,2, 3, 4, 8 and 9) have been isolated from humans (Clark 
et al., 1987; Matsuno et al., 1985; Wyatt et al., 1983). 
Most bovine rotaviruses (BRV) that have been typed 
belong to serotype 6 (Snodgrass et al., 1984), but serotype 
10 and occasionally serotype 8 rotaviruses have also been 
isolated from cattle (Snodgrass et al., 1990). In addition, 
numerous BRV strains which are serologically distinct 
from serotype 6 BRV strains NCDV or UK have been 
described (Bellinzoni et al., 1989; Bridger & Brown, 
1984; Briissow et al., 1987; Ihara et al., 1983; Murakami 
et al., 1983; Ojeh et al., 1984; Snodgrass et al., 1984, 
1990; Woode et aL, 1983; Zheng et al., 1989). It is, 
however, not clear whether these new bovine strains are 
distinct from the established rotavirus erotypes and how 
they compare to each other. In the present report we give 
a serological and biochemical description of BRV V 1005 
(Bachmann & Hess, 1981), which has been characterized 
as a second serotype of BRV (Briissow et al., 1987). 
Methods 
Viruses. Growth of rotaviruses in MA-104 cell culture, radiolabelling 
with [35S]methionine and purification of extracellular rotavirus was 
done as described previously (Brfissow et al., 1987, 1990a). 
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Polypeptide analysis. The method of limited proteolysis analysis 
follows the procedure described by Cleveland et al. (1977). Staphylococ- 
cus aureus V8 protease (10 ~tl) (Type XVII; Sigma) at a concentration f 
1 ~tg/lal was added to each slot. Two-dimensional PAGE was performed 
as described by O'Farrell (1975) with minor modifications according to 
Peters & Comings (t980). Gels were subjected to fluorography with 
Enlightning (DuPont) and exposed to X-Omat ARS X-ray films 
(Kodak) at - 70 °C. 
Hyperimmunization of  guinea-pigs. Purified viral particles were 
emulsified in Freund's complete adjuvant (first injection), in Freund's 
incomplete adjuvant (second injection), or suspended in phosphate- 
buffered saline (third injection), and administered intramuscularly 
(i.m.) into guinea-pigs. Animals had been shown to be free of 
neutralizing antibodies to BRV UK, V1005 and simian rotavirus 
(SRV) SA11 (preimmune titres < 50). Sera were analysed 20 days after 
the last injection for neutralizing activity against 100 TCIDs0 of the 
indicated rotavirus using the immunoperoxidase microtitre neutral- 
ization test of Gerna et al. (1984). Neutralizing titres are expressed as 
the reciprocal of the serum dilution reducing the number of infected 
cells by 50% 
Hyperimmunization of  rabbits. Purified virus pellets containing 
complete virions were diluted in Tris buffer containing 2~ Tween-80 to 
a final volume of 1 ml and emulsified in incomplete Freund's adjuvant. 
Each rabbit (previously shown to have a neutralizing antibody titre 
< 10 to UK calf rotavirus) received an i.m. injection of 1.0 ml of the 
emulsion at two different sites. The injections were repeated 14 days 
later and the rabbits were bled by cardiac puncture 7 to 10 days after the 
second injection. Neutralization of fluorescent focus production in 
MA-104 cells was used, essentially as described by Beards et al. (1980). 
Titres are expressed as the reciprocal of the serum dilution reducing 
fluorescent foci by 50% 
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Results 
Serological characterization of BR V VlO05 by rabbit 
hyperimmune s ra 
BRV V1005 was not significantly neutralized by rabbit 
hyperimmune s ra raised against established serotype 1, 
3, 4, 5, 6, 7, 8 and 9 rotavirus strains (Table 1). Significant 
cross-neutralization of BRV V1005 was observed with 
rabbit hyperimmune serum to the serotype 10 prototype 
BRV B223 isolated in the U.S.A. (Woode t al., 1983) 
and a recently defined British representative of serotype 
10, E4046 (Snodgrass et al., 1990). In addition, cross- 
neutralization was observed with rabbit hyperimmune 
serum to reassortant rotavirus DS-1 x UK, which de- 
rives VP7 from serotype 2 rotavirus DS-I and VP4 
from serotype 6 BRV UK (Greenberg et al., 1983) 
(Table 1). 
Hyperimmune s rum to BRV V 1005 did not neutralize 
serotype 1, 3, 4, 5, 7, 8 and 9 rotaviruses (Table 1); it did 
cross-neutralize the British serotype 10 representative, 
but notably did not cross-neutralize the prototype 
serotype 10 BRV B223 (Table 1). Rabbit hyperimmune 
serum to BRV V1005 showed significant cross-neutral- 
ization of BRV UK and reassortant rotavirus DS-1 
xUK. 
Serological characterization f BRV VlO05 by guinea-pig 
hyperimmune s ra 
BRV V1005 was not significantly neutralized by guinea- 
pig hyperimmune s ra raised against serotype 1, 2, 3, 4, 
6, 8 and 10 rotavirus trains (Table 2). Hyperimmune 
sera to BRV VI005 did not significantly cross-neutralize 
serotype l, 2 (neither strain S-2 nor DS-1), 3, 4, 5, 6, 7 and 
9 rotavirus trains (Table 2). It did neutralize serotype 10 
BRV B223. Of two guinea-pig hyperimmune sera to 
BRV V1005, one neutralized serotype 8 BRV 678 but not 
human serotype 8 rotavirus 69M (Table 2). 
Serological characterization f BR V VlO05 by monoclonal 
antibodies 
BRV V 1005 was not neutralized by monoclonal ntibody 
(MAb) UK/7; the neutralization titre of UK/7 was 
> 10000 both against BRV UK and BRV NCDV. BRV 
V1005 was not neutralized by the MAbs B223/1, B223/2, 
B223/4 and B223/N7, all of which neutralized BRV B223 
to high titres (Table 3). Of the four MAbs to BRV B223, 
three also neutralized BRV E4046. In addition BRV 
V1005 was not neutralized by MAb 57-8 (Benfield et al., 
1987), which neutralized serotype 10 BRV strains B223 
and E4046 (Table 3) as well as serotype 3, 4, 6 and 9 
rotavirus trains (Mackow et al., 1988). BRV VI005 was 
1 2 3 4 
Fig. 1. Limited proteolysis analysis ofthe outer shell polypeptide VP5*, 
the major tryptic leavage product of VP4, of rotaviruses UK (lane 1), 
V1005 (lane 2), NCDV (lane 3) and SAIl (lane 4) digested with S. 
aureus V8 protease. 
not neutralized (neutralization titre < 10) by MAbs 2C9, 
IC10, 4F8 and 5B8 (Shaw et al., 1985; Snodgrass et al., 
1990) which neutralized rotavirus serotypes 1,2, 3 and 5 
with neutralization titres of 81920, 20480, 40960 and 
10240, respectively. 
Polypeptide analysis 
The inner shell proteins VP1, VP2 and VP6 of BRV 
V1005 showed an identical peptide map to the corre- 
sponding polypeptides of the two BRV reference strains 
NCDV and UK and the SRV SAll (Brfissow et al., 
1990a; data not shown). 
We could identify two outer shell proteins in BRV 
V1005:VP7 and VP5*, the tryptic cleavage product of 
VP4 (Clark et al., 1981). VP5* of BRV V1005 showed a
clearly different peptide map when compared to VP5* of 
BRV NCDV and SRV SA11, but it was indistinguish- 
able from the digestion pattern of VP5* from BRV UK 
(Fig. 1). The digestion map of VP7 from BRV Vl005 
differed from that obtained for VP7 from BRV UK and 
SRV SAIl (Fig. 2). 
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I 2 3 
Fig. 2. Limited proteolysis analysis of the outer shell polypeptide VP7 
of rotaviruses UK (lane l), V1005 (lane 2) and SAIl (lane 3) digested 
with S. aureus V8 protease. 
By isoelectric focusing, the VP5*s of  BRV V1005 and 
the three reference strains were separated into as many 
as three spots. VP5* of  BRV V1005 and BRV UK 
showed the most acidic pI (left of the major VP6 spot) 
and SA11 rotavirus had a VP5* species of intermediate 
pI (above the major VP6 spot), whereas BRV NCDV 
97K~ 
45K~ 
pI 5-4 6.2 6.7 
V V 
V1005 NCDV 
,4vP2 
4vP5* 
~vP6 
4vP7 
UK SA11 
Fig. 3. Two-dimensional gel electrophoresis of [35S]methionine- 
labelled structural polypeptides of purified double-shelled virions of 
rotaviruses V1005, NCDV, UK and SA11. The open arrowheads give 
the isoelectric point (pI) and Mrs of marker proteins. The filled 
arrowheads give the Mr positions of the individual rotavirus 
polypeptides. The major spot of VP6 polypeptide is encircled to give a 
reference point. 
had the most basic VP5* species (right of the major VP6 
spot) (Fig. 3). The VP7 of the BRVs separated into at 
least two spots with an isoelectric point  at pH 4.5. 
Discussion 
BRV V1005 is most probably  a new member  of  the 
serotype 10 rotaviruses which exhibits some antigenic 
drift away from the other members.  It showed a two-way 
cross-reaction with BRV E4046 and a one-way cross- 
reaction with BRV B223. However,  cross-neutral ization 
of BRV V1005 with B223-specific rabbit  serum was not 
observed with the corresponding uinea-pig serum and 
cross-neutral ization of BRV B223 with the V1005- 
Table 3. Serolog&al characterization o f  BR V VlO05 by monoclonal antibodies 
Neutralizing antibody titre* to indicated 
rotavirus 
Monoclonal 
anti body Reference B223 E4046 V 1005 
UK/7# Snodgrass et al. (1990) < 10 ND:~ < 10 
B223/1 Snodgrass et al. (1990) 1280 80 < 10 
B223/3 Snodgrass et aL (1990) 163840 81920 < 10 
B223/4 Snodgrass et al. (1990) 20480 10240 < 10 
B223/N7 Zheng et al. (1989) 5120 10240 < 10 
57-8§ Mackow et al. (1988) 81920 5120 < 10 
* As determined in the fluorescent focus neutralization test (Beards et al., 1980). 
t The neutralization titre of UK/7 was > 10000 against both BRV UK and BRV NCDV. 
~: No, Not determined. 
§ Monoclonal antibody raised against serotype 4 porcine rotavirus Gottfried (Benfield et aL, 
1987) which neutralizes serotype 3, 4, 6, 9 and 10 rotaviruses in vitro (Mackow et al., 1988; D. R. 
Snodgrass, unpublished results). 
Characterization of  bovine rotavirus VlO05 2629 
specific guinea-pig serum was not observed with the 
corresponding rabbit sera. These differences might 
imply more about differences in the ability to recognize 
certain antigens than about differences in viral 
antigenicity. 
The absence of cross-reactivity of B223-specific MAbs 
with BRV V1005 indicates that the epitopes recognized 
by these antibodies are subject to a form of antigenic 
drift (Coulson et al., 1985); BRV B223 and V1005 might 
thus represent different subtypes of  serotype 10 rotavir- 
uses. Subtypes of serotype 3 (Coulson et al., 1985) and 
serotype 4 (Gerna et al., 1988) rotaviruses have been 
described. 
A two-way cross-reaction was also observed between 
BRV Vl005 and rotavirus reassortant DS-1 x UK,  
which derives VP7 from DS-1 and VP4 from UK 
rotavirus (Greenberg et al., 1983). In addition the rabbit, 
but not the guinea-pig, antiserum to BRV V1005 showed 
cross-neutralization f  BRV UK.  These serological data 
are not strong enough to support a serological relation- 
ship between VP4 of BRV UK and BRV Vl005. It is, 
however, interesting to note that the tryptic cleavage 
product of VP4, VP5*, of rotavirus strains BRV V1005 
and BRV UK were indistinguishable by peptide map- 
ping and isoelectric focusing. On the other hand, VPS* of 
BRV NCDV and BRV UK,  which belong to the same 
serotype, showed clearly different peptide maps. This 
biochemical difference confirms earlier observations 
with reassortant viruses that these two strains possess 
antigenically distinct VP4 antigens (Hoshino et al., 
1985). Thus two distinct VP4 types are associated with 
two BRVs that belong to the same serotype, and two 
similar VP4 types are associated with two BRVs that 
belong to different serotypes. A similar situation has 
recently been described for human rotaviruses. Two 
distinct VP4 types are associated with two human 
rotaviruses (KU, K8) that both belong to serotype 1 
(Taniguchi et al., 1989) and very similar VP4 types are 
associated with human rotavirus serotypes 1, 3 and 4 
(Gorziglia et al., 1988). The existence of two independent 
neutralization antigens, VP4 and VP7 (Offit & Blavat, 
1986), evidently complicates the antigenic characteriza- 
tion of rotaviruses by the cross-neutralization test. Thus a 
binary system similar to that used for influenza A viruses 
will be more adequate for rotavirus description (Hoshino 
et al., 1985). From work with reassortant viruses we 
know that the guinea-pig hyperimmune sera showed a 
15-fold greater neutralizing-antibody titre to VP7 than to 
VP4 of the immunizing rotavirus strain (Brfissow et al., 
1990b). Development of  VP4-specific monoclonal and 
polyclonal antibodies is therefore urgently needed to 
extend the current serological classif ication of  
rotaviruses. 
We thank Miss Ute Wiegmann for technical assistance, Miss D. 
Wulliemier for photographic work and Miss V. Jossevel for typing the 
manuscript. 
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